コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 e events, methods of sequence generation and allocation concealment.
2 am, which was centrally controlled to ensure allocation concealment.
3 ze four and six and stratified by site, with allocation concealment.
4 d on the adequacy of sequence generation and allocation concealment.
5 ist was used within each stratum to preserve allocation concealment.
6 ian with a minimisation program, maintaining allocation concealment.
7 ation (by age, primary cancer, and sex) with allocation concealment.
8 misation (by age, sex, and cancer type) with allocation concealment.
9 using a random-number table with centralized allocation concealment.
10 ion was computer-generated, with centralized allocation concealment.
11 and only 13% of the trials clearly explained allocation concealment.
12 Proper randomisation rests on adequate allocation concealment.
13 a secure online database (REDCap) to achieve allocation concealment.
14 ny medical researchers confuse blinding with allocation concealment.
15 selection and confounding biases with proper allocation concealment.
16 bias for both random sequence generation and allocation concealment.
17 oper random sequence generation and adequate allocation concealment.
18 entially numbered envelopes were part of the allocation concealment.
19 ing, and <1% (4/478; 95% CI, 0%-2%) reported allocation concealment.
20 g placebo via a web-based system to maintain allocation concealment.
21 k of bias for random sequence generation and allocation concealment.
22 inding (15%), sequence generation (23%), and allocation concealment (17%); and details about actual d
24 by the Jadad score, the use of an effective allocation concealment (AC) and the existence of an inte
26 Two authors independently extracted data on allocation concealment, allocation sequence, blinding, c
28 ed (1:1) via a web and voicemail system with allocation concealment and based on a computer-generated
29 y, open-label randomized clinical trial with allocation concealment and blinded outcome assessment wa
30 esponse with lower trial quality (suboptimal allocation concealment and blinding), use of condiments,
31 ias criteria (e.g., randomization, blinding, allocation concealment) and other study design features
32 timates and adequacy of sequence generation, allocation concealment, and baseline comparability among
33 tems of selection bias (sequence generation, allocation concealment, and baseline comparability) in t
36 es of reports of random sequence generation, allocation concealment, and intent-to-treat analyses wer
38 risk of bias in multiple domains, including allocation concealment, blinding of participants and per
40 ibed an appropriate method of randomization, allocation concealment, blinding, and completeness of fo
41 re considered high quality if randomization, allocation concealment, blinding, and follow-up complete
42 tected sexual intercourse to treatment, with allocation concealment by identical opaque boxes labelle
43 Randomisation was computer generated, with allocation concealment by using sequentially numbered me
44 95% CI: 0.01 to 0.25) and inadequate/unknown allocation concealment (difference in ES = 0.15; 95% CI:
45 nce was lowered due to unclear reporting for allocation concealment, dropouts, missing data on outcom
47 appropriate sequence generation and adequate allocation concealment from January 1, 2009, to March 31
48 wever, methodologic problems such as lack of allocation concealment, inadequate random sequence gener
49 s was assessed under masked conditions using allocation concealment, Jadad score, and a CONSORT check
51 critical elements remained uncommon, such as allocation-concealment mechanism (16.1% [95% CI, 15.6%-1
52 lity varied, with uncertainty about adequate allocation concealment methods in eight trials and lack
54 graded based on the risk of bias (scored on allocation, concealment of intervention, incomplete data
55 ates of reported random sequence generation, allocation concealment, power, and intent-to-treat analy
56 ethodologic quality were blinding, method of allocation concealment, presence of mortality as a study
58 nd with inadequate or unclear (vs. adequate) allocation concealment (ratio of odds ratios, 0.93 [CrI,
60 uter-generated sequence, in a 1:1 ratio with allocation concealment to receive a (third) dose of Coro
61 and were randomly allocated (1:1) with full allocation concealment to receive a prime-boost regimen
63 Oxford using a randomisation code list with allocation concealment using opaque sealed envelopes.
71 s due to poor random sequence generation and allocation concealment was high, and performance and det
74 (n = 20) of nonsurgical trials, and adequate allocation concealment was recorded in 46% (n = 30) and
76 ised, adequate methods for randomization and allocation concealment were found in 17% and 7% of studi